- Investing.com
VEGF Market Challenges | Roche faces headwinds in its ophthalmology business as funding issues at Good Days foundation impact Vabysmo growth, reducing guidance from 20% to 15% despite market share gains. |
Vabysmo's Resilience | Delve into how Vabysmo maintains strength with 60% adoption among treatment-naive patients and positive healthcare provider feedback across multiple indications despite market contraction. |
Metabolic Expansion | Explore Roche's strategic $3.5 billion acquisition of 89bio and pegozafermin, positioning the company in the growing metabolic therapeutics market with phase 3 data expected in 2027-2028. |
Analyst Outlook | HSBC downgraded Roche from Buy to Hold with a price target reduction from CHF 338 to CHF 295, citing concerns about being a "crowded trade" and potential underperformance of oncology catalysts. |
Metrics to compare | ROG | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipROGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −44.9x | 20.3x | 12.6x | |
PEG Ratio | 0.10 | 0.05 | 0.01 | |
Price/Book | 2.1x | 3.5x | 2.4x | |
Price / LTM Sales | 3.1x | 3.4x | 2.4x | |
Upside (Analyst Target) | 9.2% | 23.6% | 24.0% | |
Fair Value Upside | Unlock | −19.7% | 4.2% | Unlock |
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components in the United States, other Americas, China, other Asia Pacific countries, Germany, Europe, the Middle East, and Africa. It operates in two Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS) segments. The AES segment offers circuit materials, ceramic substrate materials, busbars, and cooling solutions for applications in electric and hybrid electric vehicles, automotive, aerospace and defense, renewable energy, wireless infrastructure, mass transit, industrial, connected devices, and wired infrastructure markets. This segment sells its products under the curamik, ROLINX, RO4000 series, RO3000 series, RT/duroid, CLTE series, TMM, AD series, DiClad series, CuClad series, Kappa, COOLSPAN, TC series, IsoClad series, MAGTREX, IM series, 2929 Bondply, SpeedWave Prepreg, RO4400/RO4400T series, and Radix trade names. The EMS segment provides engineered material solutions, including polyurethane and silicone materials used in cushioning, gasketing, sealing, and vibration management applications; customized silicones used in flex heater and semiconductor thermal applications; and polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications. This segment sells its products under the PORON, BISCO, DeWAL, ARLON, eSorba, XRD, Silicone Engineering, and R/bak trade names. The Other segment offers elastomer components under the ENDUR trade name for applications in the general industrial market, as well as elastomer floats under the NITROPHYL trade name for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets. The company was founded in 1832 and is headquartered in Chandler, Arizona.